Cargando…
Evaluation of confirmatory data following the Article 12 MRL review for fludioxonil
The applicant Syngenta submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The applicant provided residue...
Autores principales: | Anastassiadou, Maria, Brancato, Alba, Carrasco Cabrera, Luis, Ferreira, Lucien, Greco, Luna, Jarrah, Samira, Kazocina, Aija, Leuschner, Renata, Magrans, Jose Oriol, Miron, Ileana, Nave, Stefanie, Pedersen, Ragnor, Reich, Hermine, Rojas, Alejandro, Sacchi, Angela, Santos, Miguel, Stanek, Alois, Theobald, Anne, Vagenende, Benedicte, Verani, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009037/ https://www.ncbi.nlm.nih.gov/pubmed/32626430 http://dx.doi.org/10.2903/j.efsa.2019.5812 |
Ejemplares similares
-
Evaluation of confirmatory data following the Article 12 MRL review for cymoxanil
por: Anastassiadou, Maria, et al.
Publicado: (2019) -
Evaluation of confirmatory data following the Article 12 MRL review for fluroxypyr
por: Anastassiadou, Maria, et al.
Publicado: (2019) -
Evaluation of confirmatory data following the Article 12 MRL review for aclonifen
por: Anastassiadou, Maria, et al.
Publicado: (2020) -
Evaluation of confirmatory data following the Article 12 MRL review for flonicamid
por: Anastassiadou, Maria, et al.
Publicado: (2020) -
Evaluation of confirmatory data following the Article 12 MRL review for oryzalin
por: Anastassiadou, Maria, et al.
Publicado: (2019)